Fish Oil Supplementation May Improve Lipid Profile and Reduce Inflammation in the Metabolic Syndrome
In a study involving 140 patients with the metabolic syndrome and/or non-alcoholic fatty liver disease (NAFLD), daily supplementation with fish oil (2 g/d) for a period of 6 months was found to be associated with reductions in serum triglycerides, LDL-cholesterol, H(2)O(2), MDA, TNF-alpha, and IL-6 levels. Patients who did not receive fish oil were found to have significant increases in triglycerides, LDL, H(2)O(2) and MDA, which were associated with elevated TNF-alpha and IL-6. The authors state, "...daily treatment of patients with fish oil for 6 months improved lipid profile and blocked the oxidative stress and cytokines release."
Click Here to visit the journal website. Subscription required to view the full text of the article.